Navigation Links
European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera
Date:8/19/2007

diseases. Santhera's vision is to become a leading specialty pharmaceutical company offering therapies for a number of indications in this area of high unmet medical need which includes many orphan indications with no current therapy.

Santhera currently has five clinical-stage development programs, three of which are investigating its lead compound, SNT-MC17 (INN: idebenone), in the treatment of Friedreich's Ataxia (FRDA), Duchenne Muscular Dystrophy (DMD) and Leber's Hereditary Optic Neuropathy (LHON). Another clinical program is investigating JP-1730 (INN: fipamezole) for the treatment of Dyskinesia in Parkinson's Disease (DPD) in cooperation with Juvantia, the compound's owner. The fifth program comprises SNT-317 (INN: omigapil) in Congenital Muscular Dystrophies (CMD), a compound in-licensed from Novartis. The most advanced program, SNT-MC17 in FRDA, is currently in Marketing Authorization Application process in Europe and in Phase III clinical development in the US while the other clinical programs are in Phase II. For further information, please visit http://www.santhera.com.

About Takeda

Located in Osaka, Japan, Takeda (TSE:4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products.

Aiming to become an "R&D-driven world-class pharmaceutical company", Takeda is enhancing its R&D pipeline by concentrating its management resources for that purpose in the following selected core therapeutic areas:

- lifestyle-related diseases,

- oncology and urological diseases

- central nervous system disorders, bone/joint diseases

- gastroenterological diseases

Additional information about Takeda is available through its
'/>"/>

SOURCE Santhera Pharmaceuticals AG

Copyright©2007 PR Newswire.

1

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Mirus granted European patent for gene therapy
2. Info security group announces first Eastern European chapter
3. EMD Biosciences partners with European biotech company
4. Third Wave lands European distribution deal, reports high earnings
5. Biologist who cloned Dolly the sheep believes therapeutic cloning will gain acceptance
6. Biotech crops gaining acceptance, but their full promise has yet to be fulfilled
7. Risks and returns: Building a search engine marketing portfolio
8. The write stuff: marketing with articles
9. StrandVision signs joint marketing agreement with Pacific Signage
10. CPM contributes marketing program to Michigan hospital
11. MyWeather names new president, marketing officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013  Continuing its long history of proven ... Beckman Coulter , Inc. announces the U.S. Food and ... AccuTnI+3 troponin I assay for use on its Access ... on Beckman Coulter,s troponin I test for ... the proven performance to continue providing dependability to laboratories ...
(Date:6/19/2013)... India , June 19, ... Bharat Book Bureau presents Innovative ... and Formulation Technology Licensing Opportunities ... http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/innovative-drug-delivery-systems-novel-product-and-formulation-technology-licensing-opportunities-for-generic-pharmaceutical-companies.html ) There ... or controlled release drugs approved ...
(Date:6/19/2013)... Express Diagnostics Int’l, Inc., manufacturer of DrugCheck® ... has received Class III medical device license approval from ... NxStep Onsite Drug Screen Cup in Canada. Class ... in near-patient settings, such as physicians’ offices. , The ... Class III approval for 24 different drugs and detection ...
(Date:6/18/2013)... York, NY (PRWEB) June 18, 2013 ... innovation and sustainability, the Consulate General of Switzerland in ... solar boat, Switzerland’s MS Tûranor PlanetSolar , to ... part of its DeepWater Expedition 2013 tour with scientists ... led by Capitain Gérard d’Aboville, runs exclusively on energy ...
Breaking Biology Technology:Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4
... NEW YORK, Dec. 29, 2010 Reportlinker.com ... is available in its catalogue: Molecular ... The technologies that ... fluorescent in situ hybridization (FISH), second-generation biochips ...
... 2010   Today, Gov. Bobby Jindal joined Myriant ... Port of Lake Providence Director Wyly Gilfoil to ... Lake Providence Inc., will soon begin building a ... Providence that will be the world,s largest bio-based ...
... 2010 Market Publishers Ltd informs that new in-demand ... to its catalogue " Drugs & Biotechnology ." ... regularly updated, professional patent search which not only identifies ... by a convenient online interface. ...
Cached Biology Technology:Reportlinker Adds Molecular Diagnostics Markets 2Gov. Jindal Announces Myriant Technologies to Begin Construction of New, Sustainable Specialty Chemical Plant in Lake Providence 2Gov. Jindal Announces Myriant Technologies to Begin Construction of New, Sustainable Specialty Chemical Plant in Lake Providence 3New Topical Patent Research Reports Recently Published at MarketPublishers.com 2New Topical Patent Research Reports Recently Published at MarketPublishers.com 3
(Date:6/18/2013)... of Medicine have discovered a mechanism that is used ... component of blood typically associated with clotting, were discovered ... seal it off from the rest of the body. ... this week, provide the science community with a ... known that platelets do participate in immunity, but now ...
(Date:6/18/2013)... large "dead zone" in the Gulf of Mexico and ... Bay this year, based on several NOAA-supported forecast models. ... State University, and the Louisiana Universities Marine Consortium ... "dead" zone will be between 7,286 and 8,561 square ... recorded. That would range from an area the size ...
(Date:6/18/2013)... Association for Molecular Pathology is proud to announce it ... Biology (FASEB) on July 1, 2013. The FASEB Board ... , The 26 constituent societies of FASEB represent ... for the advancement of research and education in biological ... more important now than ever," said Jennifer L. Hunt, ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4
... impair the ability of ecosystems to perform vital ... sequestrationsays the nation,s largest organization of ecological scientists. ... of America (ESA) outlines strategies that focus on ... and adapt to climate change. "Decision-makers cannot ...
... wisdom, a new study from plant biologists at UC Davis ... proteins across the membranes of chloroplasts, just as they do ... in the January issue of the journal The Plant ... a living cell is to move things across membranes, both ...
... periods do not indicate long-term trends. An assessment of hundreds ... phenomenon today is in fact nothing new," explains Dr. Dorit ... in Israel has been rising and falling over the past ... lowest levels, most of the time below the present-day level. ...
Cached Biology News:Managing ecosystems in a changing climate 2Managing ecosystems in a changing climate 3Green plant transport mystery solved 2The sea level has been rising and falling over the last 2,500 years 2
... The Label IT siRNA Tracker ... Reagent provides a straight forward approach ... of your design, in an efficient ... tracking experiments. Subcellular localization and functional ...
... siRNA Tracker Intracellular Localization Kit with ... forward approach to directly label and ... an efficient yet non-destructive manner, for ... and functional inhibition of target gene ...
... Gasket slide kit (1x 22K gasket/slide) G2534-60003 ... or Gasket slide kit (2x 11K ... slides offered in either 11K or 22K microarray feature ... gaskets are carefully fabricated and batch tested to ensure ...
... self locking design in ice/water bath ... product number, created to easily match ... availability yet, please order under the ... customer service for assistance. ID clarifier: ...
Biology Products: